OPTOVUE, INC.

OPTOVUE, INC. specializes in the design and manufacturing of advanced medical imaging devices, with a technical focus on optical coherence tomography (OCT) systems and high-resolution diagnostic instrumentation. The company develops proprietary hardware and software platforms that enable non-invasive, real-time cross-sectional imaging of biological tissues, primarily for ophthalmic and dermatological applications. Their expertise lies in integrating precision optics, low-coherence interferometry, and real-time signal processing to deliver clinically validated diagnostic tools used in clinical and research settings. Key differentiators include miniaturized probe designs, automated image analysis algorithms, and FDA-cleared software workflows that enhance diagnostic accuracy and workflow efficiency. Award history is not available to infer specific agency engagements or contract patterns. Consequently, no definitive relationship patterns with federal agencies can be confirmed based on the provided data. The company operates within NAICS 339115, which encompasses the manufacturing of surgical and medical instruments, particularly diagnostic imaging equipment. In practice, this translates to a market position focused on high-precision, regulated medical devices that meet FDA quality system requirements and ISO 13485 standards. OPTOVUE’s vertical specialization is in ophthalmic diagnostics, with technology tailored for early detection of retinal diseases and corneal pathologies. OPTOVUE, INC. is a small business entity structured as a 2L organization, headquartered in San Jose, California. The company holds no government certifications, including 8(a), HUBZone, or WOSB. Its government market presence is not demonstrable from available award data, and its primary commercial focus appears to be clinical and research healthcare markets rather than federal procurement channels.